Quick answers
- What is Alymsys?
- Alymsys is a brand name of Bevacizumab-maly and Bevacizumab-bvzr, a prescription medicine. The FDA NDC Directory lists 4 Alymsys products in 4 strengths and forms.
- Who makes Alymsys?
- Amneal Pharms LLC holds the FDA application for Alymsys (BLA761231, approved April 13, 2022). 1 other company (repackagers or distributors) also list Alymsys products.
- Is there a generic or store brand of Alymsys?
- Yes. The FDA NDC Directory lists 8 other products with the same active ingredients, strength and form as a Alymsys product. Ask your pharmacist whether one is right for you.
- Has Alymsys been recalled?
- No recall linked to Alymsys products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Alymsys is
Each Alymsys product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Bevacizumab-maly · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| bevacizumab-maly 100 mg/4 mL injection, solution (intravenous) | Alymsys | None listed | DailyMed |
| bevacizumab-maly 400 mg/16 mL injection, solution (intravenous) | Alymsys | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bevacizumab-maly →
Bevacizumab-bvzr · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| bevacizumab 100 mg/4 mL injection, solution (intravenous) | Alymsys | 4 products, 4 companies | DailyMed |
| bevacizumab 400 mg/16 mL injection, solution (intravenous) | Alymsys | 4 products, 4 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bevacizumab-bvzr →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761231 | Amneal Pharms LLC | April 13, 2022 | 4 |
Companies that list Alymsys
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Alymsys products.
- Valorum Biologics, LLC2 products
- Amneal Pharmaceuticals LLC2 products
Recalls
No recall linked to Alymsys products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.